[Automatic translation follows] International Center for Biomedical and Translational Research
INEM is a research center under the supervision of Inserm, Université Paris Cité and CNRS. INEM brings together nearly 300 professionals spread across 21 research teams and research support services.
Research at INEM focuses on diseases caused by the interaction between heredity and environmental factors. These diseases mainly affect children and young people, and include (auto)immune disorders, hematological diseases, infectious diseases, kidney diseases, cystic fibrosis, endocrinological disorders and metabolic diseases. INEM teams apply knowledge from basic and clinical research to develop innovative diagnostic and therapeutic strategies.
The close interaction between research teams and clinical departments creates a highly dynamic environment and promotes translational research "from the laboratory to the patient's bedside".
INEM is a research center supported by INSERM, Université Paris Cité and the CNRS. INEM brings together nearly 300 professionals within 21 research teams and research support services. Research at INEM focuses on diseases caused by the interaction between heredity and environmental factors. These diseases mainly affect children and young people and include (auto)immune disorders, hematological diseases, infectious diseases, kidney diseases, cystic fibrosis, endocrinological disorders and metabolic diseases. INEM teams apply knowledge from basic and clinical research to develop innovative diagnostic and therapeutic strategies. The close interaction between research teams and clinical departments creates a highly dynamic environment and promotes translational research “from bench to bedside”.
Centre international de recherche biomédicale et translationnelle
L'INEM est un Centre de recherche placé sous les tutelles de l’Inserm, de l’Université Paris Cité et du CNRS. L’INEM rassemble près de 300 professionnels répartis au sein de 21 équipes de recherche et de services d’appui à la recherche.
La recherche à l'INEM se concentre sur les maladies causées par l'interaction entre l'hérédité et les facteurs environnementaux. Ces maladies affectent principalement les enfants et les jeunes, et englobent les troubles (auto) immuns, les maladies hématologiques, les maladies infectieuses, les maladies rénales, la fibrose kystique, les troubles endocrinologiques et les maladies métaboliques. Les équipes de l'INEM appliquent des connaissances issues de la recherche fondamentale et clinique pour développer des stratégies diagnostiques et thérapeutiques innovantes.
L'interaction étroite entre les équipes de recherche et les départements cliniques crée un environnement hautement dynamique et favorise la recherche translationnelle «du laboratoire au lit du malade».
INEM is a research center supported by INSERM, Université Paris Cité and the CNRS. INEM brings together nearly 300 professionals within 21 research teams and research support services. Research at INEM focuses on diseases caused by the interaction between heredity and environmental factors. These diseases mainly affect children and young people and include (auto)immune disorders, hematological diseases, infectious diseases, kidney diseases, cystic fibrosis, endocrinological disorders and metabolic diseases. INEM teams apply knowledge from basic and clinical research to develop innovative diagnostic and therapeutic strategies. The close interaction between research teams and clinical departments creates a highly dynamic environment and promotes translational research “from bench to bedside”.
Page d'accueil | INEM
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Agence VU' | Other 19 Nov 2024 | | ||
ARTiDe biotech, deeptech | Other 11 Nov 2024 | | ||
France Sclérose en Plaques healthtech | Other 11 Nov 2024 | | ||
Shanghai Jiao Tong University School of Medicine edtech | Other 4 Nov 2024 | | ||
Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation deeptech | Other 28 Oct 2024 | | ||
DrawInScience | Other 21 Oct 2024 | | ||
HÔPITAL NECKER | Other 2 Sep 2024 | | ||
NEJM Group healthtech | Other 31 Jul 2024 | | ||
Helmholtz Munich biotech, deeptech, healthtech, Research Services | Other 28 Oct 2024 | | ||
A*STAR - Agency for Science, Technology and Research Research Services | Other 4 Nov 2024 | |